EUVIMEDEUVIMED entdecken
Crossref

Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Haoting Shi iD, Jiahui Huang, Xiaosong Chen iD, Kunwei Shen iD

Journal of Clinical Oncology · 20.08.2026 · 44 (24) · 2357-2358

DOI: 10.1200/jco-26-00605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.08.2026. Verfasst von Haoting Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Haoting Shi, MD; Jiahui Huang, MD; Xiaosong Chen, MD; and Kunwei Shen, MD; Department of General Surgery, Comprehensive Breast Health Center, Ruijin …. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Haoting Shi, MD; Jiahui Huang, MD; Xiaosong Chen, MD; and Kunwei Shen, MD; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,…

ORCID-Profile: Haoting Shi, Xiaosong Chen, Kunwei Shen

Zitieren

APA

Shi, H., Huang, J., Chen, X., & Shen, K. (2026). Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection. Journal of Clinical Oncology, 44(24), 2357-2358. https://doi.org/10.1200/jco-26-00605

Vancouver

Shi H, Huang J, Chen X, Shen K. Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection. Journal of Clinical Oncology. 2026;44(24):2357-2358. doi:10.1200/jco-26-00605

BibTeX
@article{Shi2026,
  author = {Shi, Haoting and Huang, Jiahui and Chen, Xiaosong and Shen, Kunwei},
  title = {Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {24},
  pages = {2357--2358},
  doi = {10.1200/jco-26-00605}
}
Kostenlos starten →